165 related articles for article (PubMed ID: 32790146)
21. SIOP PODC Adapted treatment guidelines for low grade gliomas in low and middle income settings.
Hessissen L; Parkes J; Amayiri N; Mushtaq N; Sirachainan N; Anacak Y; Mitra D; Figaji A; Schouten-van Meeteren A; Sullivan M; Burger H; Davidson A; Bouffet E; Bailey S
Pediatr Blood Cancer; 2017 Dec; 64 Suppl 5():. PubMed ID: 29297618
[TBL] [Abstract][Full Text] [Related]
22. Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy.
Inge TH; Pfluger P; Zeller M; Rose SR; Burget L; Sundararajan S; Daniels SR; Tschöp MH
Nat Clin Pract Endocrinol Metab; 2007 Aug; 3(8):606-9. PubMed ID: 17643131
[TBL] [Abstract][Full Text] [Related]
23. Clinical characteristics and effects of GH replacement therapy in adults with childhood-onset craniopharyngioma compared with those in adults with other causes of childhood-onset hypothalamic-pituitary dysfunction.
Yuen KC; Koltowska-Häggström M; Cook DM; Fox JL; Jönsson PJ; Geffner ME; Abs R
Eur J Endocrinol; 2013 Oct; 169(4):511-9. PubMed ID: 23904277
[TBL] [Abstract][Full Text] [Related]
24. Craniopharyngioma.
Müller HL
Endocr Rev; 2014 Jun; 35(3):513-43. PubMed ID: 24467716
[TBL] [Abstract][Full Text] [Related]
25. The Diagnosis and Treatment of Craniopharyngioma.
Müller HL
Neuroendocrinology; 2020; 110(9-10):753-766. PubMed ID: 31678973
[TBL] [Abstract][Full Text] [Related]
26. Childhood craniopharyngioma: current controversies on management in diagnostics, treatment and follow-up.
Müller HL
Expert Rev Neurother; 2010 Apr; 10(4):515-24. PubMed ID: 20367205
[TBL] [Abstract][Full Text] [Related]
27. A Framework for Adapted Nutritional Therapy for Children With Cancer in Low- and Middle-Income Countries: A Report From the SIOP PODC Nutrition Working Group.
Ladas EJ; Arora B; Howard SC; Rogers PC; Mosby TT; Barr RD
Pediatr Blood Cancer; 2016 Aug; 63(8):1339-48. PubMed ID: 27082376
[TBL] [Abstract][Full Text] [Related]
28. SIOP-PODC adapted risk stratification and treatment guidelines: Recommendations for neuroblastoma in low- and middle-income settings.
Parikh NS; Howard SC; Chantada G; Israels T; Khattab M; Alcasabas P; Lam CG; Faulkner L; Park JR; London WB; Matthay KK;
Pediatr Blood Cancer; 2015 Aug; 62(8):1305-16. PubMed ID: 25810263
[TBL] [Abstract][Full Text] [Related]
29. Current strategies in diagnostics and endocrine treatment of patients with childhood craniopharyngioma during follow-up--recommendations in KRANIOPHARYNGEOM 2000.
Müller HL; Gebhardt U; Etavard-Gorris N; Kolb R; Warmuth-Metz M; Sörensen N
Onkologie; 2005 Mar; 28(3):150-6. PubMed ID: 15772466
[TBL] [Abstract][Full Text] [Related]
30. SIOP PODC adapted treatment recommendations for standard-risk medulloblastoma in low and middle income settings.
Parkes J; Hendricks M; Ssenyonga P; Mugamba J; Molyneux E; Schouten-van Meeteren A; Qaddoumi I; Fieggen G; Luna-Fineman S; Howard S; Mitra D; Bouffet E; Davidson A; Bailey S;
Pediatr Blood Cancer; 2015 Apr; 62(4):553-64. PubMed ID: 25418957
[TBL] [Abstract][Full Text] [Related]
31. [Hypopituitarism mode in patients with craniopharyngioma in relation to tumor growth pattern].
Qi ST; Peng JX; Pan J; Fan J; Zhang SC; Liu Y; Bao Y; Qiu BH; Wu XY
Zhonghua Yi Xue Za Zhi; 2018 Jan; 98(1):19-24. PubMed ID: 29343024
[No Abstract] [Full Text] [Related]
32. Diagnosis, treatment, clinical course, and prognosis of childhood-onset craniopharyngioma patients.
Müller HL
Minerva Endocrinol; 2017 Dec; 42(4):356-375. PubMed ID: 28181780
[TBL] [Abstract][Full Text] [Related]
33. Improving Care for Children With Cancer in Low- and Middle-Income Countries--a SIOP PODC Initiative.
Arora RS; Challinor JM; Howard SC; Israels T
Pediatr Blood Cancer; 2016 Mar; 63(3):387-91. PubMed ID: 26797891
[TBL] [Abstract][Full Text] [Related]
34. Risk-adapted, long-term management in childhood-onset craniopharyngioma.
Müller HL
Pituitary; 2017 Apr; 20(2):267-281. PubMed ID: 27604996
[TBL] [Abstract][Full Text] [Related]
35. Trends in treatment and outcomes of pediatric craniopharyngioma, 1975-2011.
Cohen M; Bartels U; Branson H; Kulkarni AV; Hamilton J
Neuro Oncol; 2013 Jun; 15(6):767-74. PubMed ID: 23486689
[TBL] [Abstract][Full Text] [Related]
36. Outcome of Chinese children with craniopharyngioma: a 20-year population-based study by the Hong Kong Pediatric Hematology/Oncology Study Group.
Liu AP; Tung JY; Ku DT; Luk CW; Ling AS; Kwong DL; Cheng KK; Ho WW; Shing MM; Chan GC
Childs Nerv Syst; 2020 Mar; 36(3):497-505. PubMed ID: 31974662
[TBL] [Abstract][Full Text] [Related]
37. Craniopharyngioma with panhypopituitarism; case report with clinical and pathological study.
McGAVACK TH; SACCONE A
J Clin Endocrinol Metab; 1946 Dec; 6(6):776-96. PubMed ID: 20288018
[No Abstract] [Full Text] [Related]
38. Excess mortality after craniopharyngioma treatment: are we making progress?
Qiao N
Endocrine; 2019 Apr; 64(1):31-37. PubMed ID: 30569259
[TBL] [Abstract][Full Text] [Related]
39. SIOP PODC adapted risk stratification and treatment guidelines: Recommendations for acute myeloid leukemia in resource-limited settings.
Bansal D; Davidson A; Supriyadi E; Njuguna F; Ribeiro RC; Kaspers GJL
Pediatr Blood Cancer; 2023 Nov; 70(11):e28087. PubMed ID: 31774234
[TBL] [Abstract][Full Text] [Related]
40. Fractionated proton radiation treatment for pediatric craniopharyngioma: preliminary report.
Luu QT; Loredo LN; Archambeau JO; Yonemoto LT; Slater JM; Slater JD
Cancer J; 2006; 12(2):155-9. PubMed ID: 16630407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
